Back to Journals » OncoTargets and Therapy » Volume 15

HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer [Retraction]

Authors Gao G , Shi X, Shen J

Received 16 September 2022

Accepted for publication 16 September 2022

Published 23 September 2022 Volume 2022:15 Pages 1041—1042

DOI https://doi.org/10.2147/OTT.S390084



Gao G, Shi X, Shen J. Onco Targets Ther. 2021;14:3881—3894.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The first author (Gao G) has informed the journal that they the published the same article (https://doi.org/10.1186/s12935-021-02058-9) with the journal, Cancer Cell International, without notifying either journal of the dual submission. The author (Gao G) has acknowledged that he used the same or highly similar data from the original manuscript that was used for the article published in Cancer Cell International without the consent of his co-authors. The submission was then made to OncoTargets and Therapy after altering the author list without the knowledge of his co-authors.

The Editor has agreed to the authors request to retract the article.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.